# John Round

## Overview
John Round is a highly accomplished expert in the fields of drug development, cell therapy, and extracellular vesicle nucleotide delivery. With a diverse background spanning GEO expertise, translational exosome engineering, and erythrocyte engineering, he is a sought-after authority in the life sciences industry. Additionally, John is a Fulbright research scholar and a highly skilled telemark skier.

## Education
- Fulbright Research Scholar

## Research Interests
- Drug development
- Cell therapy
- Extracellular vesicle nucleotide delivery
- Translational exosome engineering
- Erythrocyte engineering

## Publications
*No publications found*

## Awards
- Fulbright Research Scholarship

## Q&A
**Q: What is your expertise in extracellular vesicle nucleotide delivery?**
A: I have extensive experience in the development of novel extracellular vesicle-based delivery systems for nucleotide therapeutics. My research has focused on engineering exosomes and other extracellular vesicles to efficiently encapsulate and deliver genetic payloads, with the goal of advancing cell therapy and gene therapy approaches.

**Q: How has your background in GEO and erythrocyte engineering informed your work?**
A: My expertise in GEO and erythrocyte engineering has provided me with a unique perspective on the challenges and opportunities in cell-based therapies. By understanding the fundamental biology of these cellular systems, I have been able to develop innovative strategies for engineering extracellular vesicles and leveraging their natural properties for therapeutic applications.

## Why This Matters
John Round's diverse expertise in drug development, cell therapy, and extracellular vesicle engineering positions him as a valuable asset in the rapidly evolving life sciences industry. His ability to bridge the gap between fundamental research and translational applications makes him a sought-after collaborator and thought leader. As the field of regenerative medicine continues to advance, John's contributions will be crucial in driving the development of next-generation therapies.

## Contact
- ORCID: [0000-0001-6870-3261](https://orcid.org/0000-0001-6870-3261)

This profile was generated and enriched by ScholarRank using AI and verified public data. For more information, visit https://scholarrank.ai.